Sodium Bicarbonate Antacid
- Product NDC
- 53145-390
- 11-digit product format
- 531450390
- Labeler code
- 53145
- Product ID
- 53145-390_3a8afea2-5d9e-1392-e063-6294a90aca43
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sodium Bicarbonate
- Dosage form
- POWDER
- Route
- ORAL
- Labeler
- Menper Distributors Inc.
- Application
- M001
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2017-01-01
- Substance
- SODIUM BICARBONATE
- Active strength
- 2.616 g/2.616g
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 53145-390-04 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 53145-390-16 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 53145-390-08 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 53145-390-04 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 53145-390-16 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 53145-390-08 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 53145-390-04 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 53145-390-16 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 53145-390-08 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 53145-390-04 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 53145-390-16 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 53145-390-08 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 53145-390-04 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 53145-390-16 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 53145-390-08 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 53145-390-04 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 53145-390-16 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 53145-390-08 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 53145-390-08 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 53145-390-16 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 53145-390-04 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sodium Bicarbonate Antacid
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SODIUM BICARBONATE | 2.616 g/2.616g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8MDF5V39QO | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6efb4da0-03ae-4df6-acd7-e8023d20d4b3 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53145-390-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0fdb-f424-e053-dadaa90a57ce | Sodium Bicarbonate Antacid |
| 53145-390-08 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0fdb-f424-e053-dadaa90a57ce | Sodium Bicarbonate Antacid |
| 53145-390-16 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0fdb-f424-e053-dadaa90a57ce | Sodium Bicarbonate Antacid |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53145-390-04 | Sodium Bicarbonate Antacid | 113 g in 1 BOTTLE | POWDER | 113 | 3 | |
| 53145-390-08 | Sodium Bicarbonate Antacid | 227 g in 1 BOTTLE | POWDER | 227 | 3 | |
| 53145-390-16 | Sodium Bicarbonate Antacid | 454 g in 1 BOTTLE | POWDER | 454 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MAXIMUM STRENGTH ANTACID | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE | WAL-MART STORES, INC. | 7cc2ad32-fdff-0772-e053-2a91aa0aad9e | 2023-11-01 | Warnings | M001 |
| MAXIMUM STRENGTH ANTACID CHERRY | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE | WAL-MART STORES, INC. | 7cc2771e-abd7-4120-e053-2a91aa0a8af0 | 2023-11-01 | Warnings | M001 |
| MINTOX MAXIMUM STRENGTH | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE | Proficient Rx LP | b7711b50-c14a-44d6-b647-1f31284f87ea | 2023-11-01 | Warnings | M001 |
| MAXIMUM STRENGTH ANTACID AND ANTIGAS | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE | VALU MERCHANDISERS COMPANY | 5e811783-cbf6-d0e3-e053-2991aa0ae69f | 2023-10-31 | Warnings | M001 |
| REGULAR STRENGTH ANTACID | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE | CVS | 5f880b43-2977-7a2d-e053-2991aa0a024d | 2023-10-31 | Warnings | M001 |
| MAXIMUM STRENGTH ANTACID | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE | CVS PHARMACY | d5661964-9d2c-7a3d-e053-2995a90a86ef | 2023-10-31 | Warnings | M001 |
| EXTRA STRENGTH HEARTBURN RELIEF | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | CVS PHARMACY,INC. | 53fc327e-e345-26f2-e054-00144ff8d46c | 2023-10-31 | Warnings | M001 |
| MAXIMUM STRENGTH ANTACID AND ANTIGAS CHERRY | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE | VALU MERCHANDISERS COMPANY | 5e94cb90-b616-dcfe-e053-2a91aa0ada72 | 2023-10-31 | Warnings | M001 |
| CALCIUM CARBONATE CHEWABLE ANTACID | CALCIUM CARBONATE | Geri-Care Pharmaceutical Corp | 27d9b505-08bd-4261-a59d-6ddc4031be32 | 2023-10-25 | Warnings | M001 |
| CALCIUM CARBONATE | CALCIUM CARBONATE | Blessings International | 99d7e467-a3db-b4f0-e053-2a95a90a900f | 2023-10-25 | Warnings | M001 |
| Sodium Bicarbonate | SODIUM BICARBONATE | APNAR PHARMA LP | e206c240-55c2-2d00-e053-2a95a90a1779 | 2023-10-21 | Boxed warning, Warnings | M001 |
| Magnesium Oxide | MAGNESIUM OXIDE | APNAR PHARMA LP | e4ef2224-07e4-e913-e053-2995a90a28ed | 2023-10-21 | Warnings | M001 |
| Magnesium Oxide 400mg | MAGNESIUM OXIDE 400MG | Allegiant Health | 2ea68874-8c20-4284-bd0a-f07768057b83 | 2019-01-28 | Warnings | M001 |
| Calcium Antacid | CALCIUM CARBONATE | Allegiant Health | 51dd53e8-22ff-4967-9124-f15c3986e4dd | 2017-11-17 | Warnings | M001 |
| Calcium Antacid | CALCIUM CARBONATE | Allegiant Health | 551d6135-2650-4c27-a20d-d56a9aba7b71 | 2017-11-08 | Warnings | M001 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 53145-390-04 | 53145039004 | 113 g in 1 BOTTLE (53145-390-04) | 113 g | 2017-01-01 | No | No | Current |
| 53145-390-08 | 53145039008 | 227 g in 1 BOTTLE (53145-390-08) | 227 g | 2017-01-01 | No | No | Current |
| 53145-390-16 | 53145039016 | 454 g in 1 BOTTLE (53145-390-16) | 454 g | 2017-01-01 | No | No | Current |